Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor.
about
Designing liver resections and pushing the envelope with resections for hepatic colorectal metastasesFuture directions for monitoring treatment response in colorectal cancerEarly survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.CT texture analysis in colorectal liver metastases: A better way than size and volume measurements to assess response to chemotherapy?Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI.Perioperative Physiotherapy for Total Ankle Replacement in Patients with Inherited Bleeding Disorders: Outline of an Algorithm.Intra-arterial therapies for liver cancer: assessing tumor response.The prognostic value of fluorodeoxyglucose positron emission tomography metabolic tumor volume in solitary colorectal liver metastasis.Resistance mechanisms to drug therapy in breast cancer and other solid tumors: An opinion.Retrospective analysis of pathological response in colorectal cancer liver metastases following treatment with bevacizumab.Tumor histopathology predicts outcomes after resection of colorectal cancer liver metastases treated with and without pre-operative chemotherapy.Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour.Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy
P2860
Q26864128-6FCC8CDA-3667-4CC0-8293-B5845FC7865EQ27008428-78FFEDF5-5E82-440E-885F-DAF71AED2428Q35691040-AB821253-B3C5-4C0E-9B5D-F435BB5E407CQ36719842-94E38D00-B588-43C9-A36B-BE8FCDCE68E4Q38265114-D2CFA91E-6460-4705-9F01-F38792BBB2AFQ38995205-6180DF91-B05D-445E-85AF-248DF6B64450Q39041266-C1B97FFC-7CD9-40D2-A9D3-EB4180721CD9Q39566044-1032CF6C-3032-4411-B8F3-B56B0CEE396AQ40989687-81BE1AAD-10C5-4221-9A26-763776AF861FQ44895824-72CE46BC-61A0-483E-94B7-D883B84D4F30Q45032127-A33D6C33-69C8-4B2D-9EEA-1DBD189DD58AQ46463662-709C3B20-0C3F-4F2C-9A0B-40FB6B9BAED0Q53521945-5928F7E9-4D4E-4471-84FC-FD971728A415Q56524446-5C472AB9-AFA5-47D0-9FB7-4E9492F2ED03
P2860
Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Assessment of chemotherapy res ...... hologic residual viable tumor.
@en
type
label
Assessment of chemotherapy res ...... hologic residual viable tumor.
@en
prefLabel
Assessment of chemotherapy res ...... hologic residual viable tumor.
@en
P2093
P1476
Assessment of chemotherapy res ...... hologic residual viable tumor.
@en
P2093
Charles R Scoggins
Cliff Tatum
Glenda G Callender
Kelly M McMasters
Larry Kelly
Michael E Egger
Michael Nowacki
Robert C G Martin
Robert M Cannon
Tiffany L Metzger
P304
845-56; discussion 856-7
P356
10.1016/J.JAMCOLLSURG.2012.12.037
P577
2013-02-13T00:00:00Z